Literature DB >> 16567988

Three-year surveillance of community onset health care-associated staphylococcus aureus infections in children.

Kristina G Hultén1, Sheldon L Kaplan, Blanca E Gonzalez, Wendy A Hammerman, Linda B Lamberth, James Versalovic, Edward O Mason.   

Abstract

BACKGROUND: Staphylococcus aureus causes skin and soft tissue or invasive infections in children in the community, in the hospital or in other ways associated with the health care system (HCA).
METHODS: Prospective community-acquired S. aureus infection surveillance at Texas Children's Hospital was initiated on August 1, 2001. Community onset HCA (CO HCA) infections were identified. Demographic and clinical data were collected. Antibiotic susceptibilities were determined. Data were analyzed by chi or Student's t test. CO HCO-isolates were characterized by pulsed field gel electrophoresis and staphylococcal chromosomal cassette carrying the mecA methicillin-resistant gene (SCCmec) typing.
RESULTS: From August 1, 2001 to July 31, 2004, 61.5% of 322 in year 1, 62.9% of 259 in year 2 and 56.9% of 318 in year 3 of CO HCA isolates were methicillin-resistant S. aureus (MRSA). Among the CO HCA-MRSA isolates, 8.9% of 542 were from children with invasive infections compared with 24.1% of 357 CO HCA-methicillin-susceptible S. aureus (MSSA; P < 0.001). Sixty-six percent of children with CO HCA-S. aureus isolates were admitted to the hospital. Clindamycin resistance increased over the 3 years (CO HCA-MRSA, from 3.5% to 18.8%, P < 0.001; CO HCA-MSSA, from 3.2% to 10.2%, P = 0.053). Thirty-three of 35 (94.3%) CO HCA-MRSA carried SCCmecIV; 30 were USA300. Only 3 of 35 MSSA were related to USA300 by pulsed field gel electrophoresis.
CONCLUSIONS: CO HCA-S. aureus infections remained steady over the 3-year study at Texas Children's Hospital. Clindamycin resistance increased >4-fold for CO HCA-S. aureus isolates over the 3 years and is no longer appropriate for empiric treatment of invasive infections suspected to be caused by CO HCA-MRSA at our hospital. In our setting, CO HCA-MRSA infections are steady in number despite substantial increases in community-acquired MRSA infections and both being related to the same clone.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16567988     DOI: 10.1097/01.inf.0000207404.50143.1e

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  36 in total

Review 1.  Prevention of Recurrent Staphylococcal Skin Infections.

Authors:  C Buddy Creech; Duha N Al-Zubeidi; Stephanie A Fritz
Journal:  Infect Dis Clin North Am       Date:  2015-09       Impact factor: 5.982

2.  Public health implications of MRSA in Canada.

Authors:  Upton D Allen
Journal:  CMAJ       Date:  2006-06-27       Impact factor: 8.262

3.  Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children.

Authors:  J Chase McNeil; Kristina G Hulten; Sheldon L Kaplan; Edward O Mason
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

4.  Pediatric antibody response to community-acquired Staphylococcus aureus infection is directed to Panton-Valentine leukocidin.

Authors:  Eric L Brown; M Gabriela Bowden; Rebecca S Bryson; Kristina G Hulten; Andrea S Bordt; Andrea Forbes; Sheldon L Kaplan
Journal:  Clin Vaccine Immunol       Date:  2008-11-12

5.  Trends and characteristics of culture-confirmed Staphylococcus aureus infections in a large U.S. integrated health care organization.

Authors:  G Thomas Ray; Jose A Suaya; Roger Baxter
Journal:  J Clin Microbiol       Date:  2012-03-14       Impact factor: 5.948

6.  Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: A perspective for Canadian health care practitioners.

Authors:  Michelle Barton; Michael Hawkes; Dorothy Moore; John Conly; Lindsay Nicolle; Upton Allen; Nora Boyd; Joanne Embree; Liz Van Horne; Nicole Le Saux; Susan Richardson; Aideen Moore; Dat Tran; Valerie Waters; Mary Vearncombe; Kevin Katz; J Scott Weese; John Embil; Marianna Ofner-Agostini; E Lee Ford-Jones
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

7.  Decreased susceptibilities to Retapamulin, Mupirocin, and Chlorhexidine among Staphylococcus aureus isolates causing skin and soft tissue infections in otherwise healthy children.

Authors:  J Chase McNeil; Kristina G Hulten; Sheldon L Kaplan; Edward O Mason
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

8.  Impact of Health Care Exposure on Genotypic Antiseptic Tolerance in Staphylococcus aureus Infections in a Pediatric Population.

Authors:  J Chase McNeil; Kristina G Hultén; Edward O Mason; Sheldon L Kaplan
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

Review 9.  Treatment strategies for methicillin-resistant Staphylococcus aureus infections in pediatrics.

Authors:  Jason G Newland; Gregory L Kearns
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

10.  Antibiotic selection for purulent skin and soft-tissue infections in ambulatory care: a decision-analytic approach.

Authors:  Adam L Hersh; Peggy S Weintrub; Michael D Cabana
Journal:  Acad Pediatr       Date:  2009 May-Jun       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.